Dr. Dimitrov is a multidisciplinary scientist and a serial entrepreneur. KD Innovations is his third start-up company. Previously, Dr. Dimitrov was Founder and Managing Director of Digital Diagnostics, Pty. Ltd—a spinout company from the Australian Institute for Bioengineering and Nanotechnology (AIBN) where Dr. Dimitrov was a Group Leader from 2006 until 2012. Prior to AIBN, he was the Founder and CTO of NanoString Technologies in Seattle, WA. Dr. Dimitrov founded NanoString Technologies to commercialize his invention of fluorescent nanobarcodes for single molecules. Prior to NanoString, Dr. Dimitrov was the Director of the Gene Expression Laboratory at the Institute for Systems Biology in Seattle, playing a significant role in the growth and formation of these institutions.
During his research career, Dr. Dimitrov has made many significant discoveries. Most importantly he pioneered and patented the barcodes for single-molecule detection, which are currently marketed by NanoString Technologies. More recently, Dr. Dimitrov invented and developed products for rapid and sensitive detection of proteolytic activities with handheld electronic devices. These products are currently in the process of clinical testing and commercialization by Exactus Diagnostics and will find applications in detection of fibrinolysis and metastatic degradation of extracellular matrices.
Dr. Dimitrov holds a Ph.D. in Biochemistry from Baylor College of Medicine, and M.Sc. in Biotechnology from Sofia University.